← Leaderboards
Hartmut Land
University Of Rochester
$15,247,075
Attributed
$15,247,075
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$15,247,075 · 8
By mechanism
R01$6,575,385 · 4
R35$5,934,906 · 1
T32$1,648,613 · 1
P30$801,398 · 1
P50$286,773 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Ignacio E. Sanz$71,521,451
- Gary R Morrow$66,207,520
- James Palis$20,960,389
- Gloria S Pryhuber$27,133,178
- David A Pearce$11,215,112
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsGeneticGenesInvestigationCell TransformationOncogenicCancer CellResponseMutationPhenotypeProgramsRegulationOncogenesMediator Of Activation ProteinCancer TherapyTraitMediatingMolecular AnalysisCell MotilityNovel StrategiesIn VivoCancer InterventionBase
Grant awards (37)
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer$853,881
R35 · FY2021 · CA · contact PI
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer$867,125
R35 · FY2020 · CA · contact PI
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer$848,580
R35 · FY2019 · CA · contact PI
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer$882,525
R35 · FY2018 · CA · contact PI
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer$896,385
R35 · FY2017 · CA · contact PI
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer$909,071
R35 · FY2016 · CA · contact PI
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer$677,339
R35 · FY2015 · CA · contact PI
Pancreatic Cancer Vulnerabilities Downstream of Cooperating Oncogenic Mutations$412,619
R01 · FY2015 · CA · contact PI
Pancreatic Cancer Vulnerabilities Downstream of Cooperating Oncogenic Mutations$412,619
R01 · FY2014 · CA · contact PI
Cancer Center Training - Experimental Therapy Models$240,682
T32 · FY2013 · CA · contact PI
Gene Networks Essential to Colon Cancer Phenotype$522,854
R01 · FY2012 · CA · contact PI
Cancer Center Training - Experimental Therapy Models$218,388
T32 · FY2012 · CA · contact PI
Developmental Research Program$59,196
P50 · FY2012 · CA · contact PI
Gene Networks Essential to Colon Cancer Phenotype$524,632
R01 · FY2011 · CA · contact PI
Cooperation of oncogenic mutations in the control of malignancy$283,822
R01 · FY2011 · CA · contact PI
Cancer Center Training - Experimental Therapy Models$247,098
T32 · FY2011 · CA · contact PI
Developmental Research Program$55,755
P50 · FY2011 · CA · contact PI
Gene Networks Essential to Colon Cancer Phenotype$542,748
R01 · FY2010 · CA · contact PI
Cancer Center Training - Experimental Therapy Models$357,320
T32 · FY2010 · CA · contact PI
Gene synergy landscapes of breast and prostate cancer$311,547
P30 · FY2010 · CA · contact PI
Cooperation of oncogenic mutations in the control of malignancy$292,600
R01 · FY2010 · CA · contact PI
Developmental Research Program$58,338
P50 · FY2010 · CA · contact PI
Gene Networks Essential to Colon Cancer Phenotype$530,510
R01 · FY2009 · CA · contact PI
Whole genome methylation landscape of breast cancer$489,851
P30 · FY2009 · CA · contact PI
Cancer Center Training - Experimental Therapy Models$353,821
T32 · FY2009 · CA · contact PI
Cooperation of oncogenic mutations in the control of malignancy$292,600
R01 · FY2009 · CA · contact PI
Developmental Research Program$67,698
P50 · FY2009 · CA · contact PI
Gene Networks Essential to Colon Cancer Phenotype$520,366
R01 · FY2008 · CA · contact PI
Cooperation of oncogenic mutations in the control of malignancy$292,600
R01 · FY2008 · CA · contact PI
Developmental Research Program$45,786
P50 · FY2008 · CA · contact PI
Cooperation of oncogenic mutations in the control of malignancy$292,600
R01 · FY2007 · CA · contact PI
Cancer Center Training-Experimental Therapy Models$231,304
T32 · FY2006 · CA · contact PI
Multi step tumorigenesis, control of cell cycle entry$330,963
R01 · FY2005 · CA
Multi step tumorigenesis, control of cell cycle entry$330,963
R01 · FY2004 · CA
Multi step tumorigenesis, control of cell cycle entry$330,963
R01 · FY2003 · CA
Multi step tumorigenesis, control of cell cycle entry$330,963
R01 · FY2002 · CA
Multi step tumorigenesis, control of cell cycle entry$330,963
R01 · FY2001 · CA